FDA.reportPublic FDA data

phentolamine 0.75 % Ophthalmic Solution

RxCUI
2677793
RxNorm name
phentolamine 0.75 % Ophthalmic Solution
Display name
phentolamine 0.75 % Ophthalmic Solution
Full name
phentolamine 0.75 % Ophthalmic Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
96bb1e53-c2cc-4e60-a21a-db0269c371bfphentolamine 0.75 % Ophthalmic Solution [PSN] · phentolamine 7.5 MG/ML Ophthalmic Solution [SCD] · phentolamine 0.75 % Ophthalmic Solution [SY] · phentolamine 7.5 MG (as phentolamine mesylate 10 MG) per 1 ML Ophthalmic Solution [SY]44These highlights do not include all the information needed to use RYZUMVI safely and effectively. See full prescribing information for RYZUMVI. RYZUMVI™ (phentolamine ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 195220240531